Dual-fluorescence isogenic high-content screening for MUC16/CA125 selective agents (Q33982446)

30 July 2017

Dual-fluorescence isogenic high-content screening for MUC16/CA125 selective agents (English)

1 reference

30 July 2017

Thapi D Rao

1

1 reference

PubMed ID

21817115

30 July 2017

Nestor Rosales

series ordinal

2

1 reference

PubMed ID

21817115

30 July 2017

David R Spriggs

series ordinal

3

1 reference

30 July 2017

4 August 2011

1 reference

Molecular Cancer Therapeutics

30 July 2017

1 reference

30 July 2017

10

1 reference

30 July 2017

10

1 reference

30 July 2017

1939-1948

1 reference

Integrated genomic analyses of ovarian carcinoma

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191303

An accelerated pathway for targeted cancer therapies.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191303

High-content assay to identify inhibitors of dengue virus infection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191303

A high-throughput screen for alpha particle radiation protectants

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191303

Novel monoclonal antibodies against the proximal (carboxy-terminal) portions of MUC16.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191303

A miniaturized 1536-well format gamma-secretase assay

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191303

The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma: a Gynecologic Oncology Group study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191303

Urinary levels of Bcl-2 are elevated in ovarian cancer patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191303

Cancer genome sequencing: the challenges ahead

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191303

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191303

Use of isogenic human cancer cells for high-throughput screening and drug discovery

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191303

Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191303

Some Thoughts on Clinical Trials, Especially Problems of Multiplicity

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191303

More than a biomarker: CA125 may contribute to ovarian cancer pathogenesis.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191303

Vaccination of patients with advanced ovarian carcinoma with the anti-idiotype ACA125: immunological response and survival (phase Ib/II).

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3191303

Is there a "best" choice of second-line agent in the treatment of recurrent, potentially platinum-sensitive ovarian cancer?

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21817115

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Targeted cancer therapies

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21817115

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/1535-7163.MCT-11-0228

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

PubMed ID

21817115